Combining Cyproheptadine Hydrochloride With Targeted Muscle Activation Training to Treat Upper Extremity Stroke: A...

Area of Science:

• Neurorehabilitation
• Pharmacological interventions
• Motor control recovery

Background:

• Stroke survivors often experience severe, chronic upper extremity impairment.
• Restoring hand function is crucial for independence and quality of life.
• Current treatments have limitations in addressing severe, long-term motor deficits.

Purpose of the Study:

• To evaluate a novel treatment combining cyproheptadine hydrochloride with targeted muscle activation practice.
• To assess the efficacy of this combined approach for improving hand motor control in chronic stroke survivors.
• To determine if cyproheptadine hydrochloride enhances motor recovery when paired with active rehabilitation.

Main Methods:

• A double-blind, randomized controlled trial was conducted with 94 stroke survivors with severe, chronic hand impairment.
• Participants received either cyproheptadine hydrochloride or placebo, gradually increasing dosage over 3 weeks.
• Therapy involved active practice of muscle activation patterns for computer games or exoskeleton control, or passive stretching.

Main Results:

• A significant improvement in hand motor control, measured by the Graded Wolf Motor Function Test (GWMFT), was observed in groups receiving cyproheptadine and active practice.
• Approximately one-third of participants in these groups showed at least a 10% reduction in GWMFT completion time.
• Improvements were sustained at a 1-month follow-up, while the placebo/passive stretching group showed no improvement.

Conclusions:

• Stroke survivors with severe, chronic hand impairment can achieve statistically significant improvements in motor control through targeted muscle activation therapy.
• Cyproheptadine hydrochloride shows potential as an adjunctive treatment to enhance motor recovery in stroke survivors with hand impairment.
• The combination therapy offers a promising avenue for improving functional outcomes in a challenging patient population.